Heron Therapeutics, Inc. (HRTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.91
Day's range
$1

Heron Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 08/14/2026 30.05 M $12.82 M   0.00% 15.84%
CLEARLINE CAPITAL LP 08/14/2026 11.38 M $4.86 M   -6.96% 6.00%
BLACKROCK, INC. 08/07/2026 10.55 M $4.50 M   4.40% 5.56%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 8.75 M $3.74 M   0.00% 4.62%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 7.78 M $3.32 M   -0.35% 4.10%
TEJARA CAPITAL LTD 08/11/2026 6.51 M $2.78 M   2.75% 3.43%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 6.25 M $2.67 M   0.00% 3.30%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 4.27 M $1.82 M   6.51% 2.25%
MILLENNIUM MANAGEMENT LLC 08/14/2026 4.07 M $1.74 M   -46.66% 2.15%
JW ASSET MANAGEMENT, LLC 08/07/2026 3.75 M $1.60 M   0.00% 1.98%
STATE STREET CORP 08/07/2026 3.23 M $1.38 M   -16.00% 1.70%
UBS GROUP AG 08/13/2026 3.00 M $1.28 M   31.11% 1.58%
PALE FIRE CAPITAL SE 08/13/2026 2.51 M $1.07 M   -7.54% 1.32%
MARSHALL WACE, LLP 08/13/2026 2.35 M $1.01 M   100.00% 1.24%
CAPTION MANAGEMENT, LLC 08/14/2026 2.10 M $896.28 K   0.00% 1.11%
CONGRESS PARK CAPITAL LLC 07/14/2026 2.02 M $860.62 K   -50.00% 1.06%
RICHMOND BROTHERS, INC. 08/11/2026 1.79 M $764.96 K   24.75% 0.95%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.58 M $674.88 K   20.71% 0.83%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 1.55 M $663.19 K   142.19% 0.82%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.51 M $643.15 K   -12.30% 0.79%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.37 M $582.91 K   18.43% 0.72%
GOLDMAN SACHS GROUP INC 08/14/2026 1.33 M $567.54 K   25.81% 0.70%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 1.28 M $547.07 K   33.17% 0.68%
NORTHERN TRUST CORP 08/13/2026 1.22 M $522.18 K   4.35% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.22 M $519.61 K   -11.55% 0.64%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.22 M $519.61 K   100.00% 0.64%
GSA CAPITAL PARTNERS LLP 08/06/2026 1.04 M $445.00 K   892.63% 0.55%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.02 M $435.80 K   3,263.83% 0.54%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 1.00 M $1.50 M   0.00% 0.53%
CAPTION MANAGEMENT, LLC 08/14/2026 1.00 M $426.80 K   218.80% 0.53%
CM MANAGEMENT, LLC 08/13/2026 1.00 M $426.80 K   0.00% 0.53%
NEW YORK STATE COMMON RETIREMENT FUND 07/29/2026 694.17 K $296.27 K   -73.06% 0.37%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 490.79 K $209.47 K   -65.00% 0.26%
NEXPOINT ASSET MANAGEMENT, L.P. 08/14/2026 475.75 K $203.05 K   0.00% 0.25%
DIADEMA PARTNERS LP 08/14/2026 458.72 K $195.78 K   100.00% 0.24%
INVESCO LTD. 08/14/2026 406.67 K $173.57 K   24.55% 0.21%
XCELSIOR ADVISOR PARTNERS LLC 08/14/2026 405.78 K $173.19 K   42.07% 0.21%
BANK OF NEW YORK MELLON CORP 08/06/2026 395.84 K $168.94 K   -2.70% 0.21%
APEIRON RIA LLC 07/16/2026 370.58 K $158.16 K   21.24% 0.20%
SQUAREPOINT OPS LLC 08/14/2026 321.18 K $137.08 K   -62.65% 0.17%
INTEGRATED WEALTH CONCEPTS LLC 08/12/2026 318.90 K $136.11 K   233.94% 0.17%
ALLIANCEBERNSTEIN L.P. 08/14/2026 299.91 K $239.96 K   51.05% 0.16%
VIRTU FINANCIAL LLC 08/13/2026 283.24 K $121.00 K   100.00% 0.15%
TWO SIGMA INVESTMENTS, LP 08/14/2026 266.31 K $113.66 K   -16.10% 0.14%
FMR LLC 08/13/2026 226.80 K $96.80 K   289.73% 0.12%
NUVEEN, LLC 08/11/2026 221.79 K $94.66 K   -57.86% 0.12%
ABEL HALL, LLC 07/24/2026 213.19 K $90.99 K   1,160.93% 0.11%
RHUMBLINE ADVISERS 08/12/2026 195.54 K $83.48 K   5.95% 0.10%
QUINN OPPORTUNITY PARTNERS LLC 08/14/2026 175.34 K $74.84 K   0.00% 0.09%
RAYMOND JAMES FINANCIAL INC 08/14/2026 158.18 K $67.51 K   14.45% 0.08%

Heron Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 268 institutional investors and hedge funds held shares of Heron Therapeutics Inc. The most heavily invested institutionals were:

Rubric Capital Management LP: 30.05 M

Clearline Capital LP: 11.38 M

BlackRock, Inc.: 10.55 M

Velan Capital Investment Management LP: 8.75 M

VANGUARD CAPITAL MANAGEMENT LLC: 7.78 M

Tejara Capital Ltd: 6.51 M

71.13% of Heron Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 167.34 M shares in the last 24 months. This purchase volume represents approximately $167.34 M in transactions.